Three CEOs head for the exit in one filing day while Ingersoll Rand locks its chief in until 2032
Genworth, Harmony Biosciences and Utz Brands all disclosed chief executive departures on October 30, 2026, with year-end timing and very different levels of pay disclosure. Ingersoll Rand went the other way, extending its CEO and tying new equity to a decade of earnings growth.
- Genworth Financial said president and CEO Thomas J. McInerney will retire December 31, 2026; Jerome T. Upton succeeds him January 1, 2027, and Angela R. Simmons becomes CFO the same day. m:…0709
- Harmony Biosciences said CEO Jeffrey M. Dayno retires December 31, 2026, and Peter Anastasiou succeeds him January 1, 2027, with a $725,000 base salary, 75% target bonus, $1,750,000 option award and $750,000 restricted stock unit award. Self-reported m:…3946
- Utz Brands said CEO Howard Friedman is expected to depart November 30, 2026, with board member B. John Lindeman lined up as CEO of Company LLC after the pending Intersnack merger closes; stockholders vote on the merger November 13, 2026. m:…2015
- Ingersoll Rand extended CEO Vicente Reynal's employment agreement through February 2032 and granted 226,098 performance stock units tied to a 10% adjusted EPS compound annual growth target for 2027-2031. Self-reported m:…6639
- Ingersoll Rand also disclosed the retirement of SVP Michael Weatherred effective October 27, 2026, with Scott Watson and Shaun Carlson taking new segment leadership roles. m:…6639
A crowded day for the top job
Four companies filed leadership news on October 30, 2026, and three of them announced a chief executive on the way out. Genworth Financial said president and chief executive Thomas J. McInerney will retire at the close of business on December 31, 2026, with Jerome T. Upton taking over as president and chief executive and joining the board on January 1, 2027; Angela R. Simmons becomes executive vice president and chief financial officer the same day. The filing said the retirement was not the result of any disagreement over operations, policies or practices. m:…0709
Harmony Biosciences followed the same calendar. Jeffrey M. Dayno retires as president and chief executive officer on December 31, 2026, and Peter Anastasiou steps in on January 1, 2027, under a new employment agreement, after which Dayno moves to a consulting role running through January 2028. Utz Brands moved faster: chief executive Howard Friedman is expected to depart on November 30, 2026, and board member B. John Lindeman is lined up as chief executive of Company LLC after the pending merger with Intersnack Group closes. m:…3946 m:…2015
The Utz filing ties the handover to a live transaction. Stockholders vote on the merger at a special meeting on November 13, 2026, and the company used the same filing to add disclosures to its proxy statement after two stockholder complaints were filed on October 22, 2026, over the definitive proxy statement. The written post-closing employment agreement for Lindeman was still to be finalized, the filing said. m:…2015
What the handovers cost
Harmony put numbers on both sides of its transition. Dayno receives $770,000 in severance and will consult at $500 an hour, while Anastasiou's package sets a $725,000 base salary, a 75% target bonus, a $1,750,000 option award and a $750,000 restricted stock unit award. Genworth, by contrast, said new compensation terms for Upton and Simmons will come in a future amendment, leaving the price of its handover undisclosed for now. m:…3946 m:…0709
Utz disclosed Lindeman's contemplated terms: a $1,700,000 base salary and a $300,000 target bonus, with a start date of November 30, 2026, or a later mutually agreed date. The gap between the three approaches is the story for anyone tracking governance: one board priced the whole transition in the filing, one priced the incoming chief executive, and one deferred the numbers entirely. m:…2015
Ingersoll Rand, the fourth filer, went the other way. Rather than announcing a departure, it extended chief executive Vicente Reynal's employment agreement through February 2032 and added a performance-based equity package of 226,098 performance stock units, with a target bonus of 150% of his $1,200,000 base salary. The units vest against a five-year performance period from 2027 through 2031, tied to a 10% adjusted earnings-per-share compound annual growth target, with a return-on-invested-capital modifier that can move the payout by 10% in either direction. The same filing recorded the retirement of senior vice president Michael Weatherred, effective October 27, 2026, and new segment leadership roles for Scott Watson and Shaun Carlson. m:…6639
What remains open
Three questions carry into the next filings. First, what Genworth will pay Upton and Simmons, once its promised amendment arrives. Second, whether Utz stockholders approve the Intersnack merger on November 13, and whether the pending stockholder litigation changes the terms before then. Third, what baseline Ingersoll Rand's compensation committee sets for 2026 adjusted earnings per share, since that figure anchors the whole five-year payout for Reynal. m:…0709 m:…2015 m:…6639
For executives watching the pattern, the practical read is narrower than the headlines: year-end is the chosen moment for clean breaks, the pay math usually arrives in the same filing as the departure, and the exception, a deferred compensation disclosure, is itself worth noting when it appears. m:…0709 m:…3946
What is still unresolved
- What compensation Genworth will disclose for Jerome T. Upton and Angela R. Simmons in its promised future amendment.
- Whether Utz stockholders approve the Intersnack merger on November 13, 2026, and how the pending stockholder litigation resolves.
- What 2026 adjusted EPS baseline Ingersoll Rand's compensation committee sets for Reynal's performance stock units.
Provenance by Synorb. Every claim links to its source. This story was written by an agent from the Manifests listed below. Read the methodology and limitations, or send a correction.
Free to reuse, including commercially. Credit “Hanging Context, with provenance by Synorb” and link to this story. Keep the cited Manifest ids. Reuse terms v1.